Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011 Dec;11(6):628; author reply 628.
doi: 10.7861/clinmedicine.11-6-628.

'The tubercular diabetic'

Comment

'The tubercular diabetic'

Hemantha Chandrasekara et al. Clin Med (Lond). 2011 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Park JY, Kim KA, Park PW, Park CW, Shin JG. Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide Clin Pharmacol Ther 2003. 74 334–40 - PubMed
    1. Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivisto KT. Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide Clin Pharmacol Ther 2001. 69 400–610.1067/mcp.2001.115822 - DOI - PubMed
    1. Jaakkola T, Backman JT, Neuvonen M, Laitila J, Neuvonen PJ. Effect of rifampicin on the pharmacokinetics of pioglitazone Br J Clin Pharmacol 2006. 61 70–810.1111/j.1365-2125.2005.02515.x - DOI - PMC - PubMed
    1. Niemi M, Backman JT, Neuvonen M, Neuvonen PJ. Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjects Br J Clin Pharmacol 2003. 56 427–3210.1046/j.1365-2125.2003.01884.x - DOI - PMC - PubMed
    1. Hatorp V, Hansen KT, Thomsen MS. Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinide J Clin Pharmacol 2003. 43 649–60 - PubMed

MeSH terms